| | Male subjects | Female subjects |
|---|
β | Standard β | 95% CI |
P
| β | Standard β | 95% CI |
P
|
|---|
Unadjusted | 0.008 | 0.050 | 0.006–0.023 | 0.263 | 0.016 | 0.114 | 0.007–0.024 | <0.001 |
Model 1 | 0.004 | 0.031 | 0.003–0.021 | 0.319 | 0.011 | 0.075 | 0.004–0.020 | 0.010 |
Model 2 | 0.002 | 0.013 | 0.001–0.117 | 0.651 | 0.009 | 0.062 | 0.002–0.017 | 0.034 |
- Dependent variable: CIMT; Independent variable: Non-HDL-C
- β: regression coefficient. β was calculated for a 1-unit increase in Non-HDL-C
- Model 1 adjusted for age, BMI, WHR, FBG, PPG, SBP, DBP, smoking, logHOMA-IR and logHOMA-B%, Model 2 adjusted for all the other lipid levels in addition to the risk factors adjusted in Model 1
-
BMI body mass index, WHR waist-hip-ratio, FBG fasting blood glucose, PPG OGTT 2 h blood glucose, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, Non-HDL-C non high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment index for insulin resistance, HOMA-B homeostasis model assessment index for beta cell function, CIMT carotid intima-media thickness
